About ABL Diagnostics
ABL Diagnostics is a company based in Suresnes (France) founded in 2009 was acquired by Advanced Biological Laboratories in October 2021. It operates as a HealthTech, and Professional Services. ABL Diagnostics offers products and services including DeepChek® Assay, UltraGene Assay, and Nadis®.
- Headquarter Suresnes, France
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abl Diagnostics S.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Advanced Biological Laboratories
(Oct 10, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ABL Diagnostics
ABL Diagnostics offers a comprehensive portfolio of products and services, including DeepChek® Assay, UltraGene Assay, and Nadis®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Whole genome HIV-1 genotyping is provided through sequencing.
SARS-CoV-2 detection and screening are enabled via RT-PCR.
Electronic medical records are managed with this software.
Funding Insights of ABL Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ABL Diagnostics
ABL Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Advanced Biological Laboratories. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Digital tools for infectious disease management are offered to providers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ABL Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ABL Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abl Diagnostics Comparisons
Competitors of ABL Diagnostics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ABL Diagnostics
When was ABL Diagnostics founded?
ABL Diagnostics was founded in 2009.
Where is ABL Diagnostics located?
ABL Diagnostics is headquartered in Suresnes, France. It is registered at Suresnes, Ile-de-france, France.
What does ABL Diagnostics do?
ABL Diagnostics S.A. is focused on improving disease management through innovative microbiology solutions. Products and services are offered in the field of molecular diagnostics, including genotyping assays for viruses like HIV and SARS-CoV-2, real-time PCR assays for detection and quantification, and digital solutions for lab automation and data hosting. The company serves the healthcare sector by providing tools for respiratory, hepatitis, and sexually transmitted infections, among others. Instruments and consumables for DNARNA extraction and sequencing are also supplied to support clinical and research applications.
What products or services does ABL Diagnostics offer?
ABL Diagnostics offers DeepChek® Assay, UltraGene Assay, and Nadis®.
Who are ABL Diagnostics's investors?
ABL Diagnostics has 1 investor. Key investors include Advanced Biological Laboratories.